Incyte price target raised to $82 from $81 at Oppenheimer
PremiumThe FlyIncyte price target raised to $82 from $81 at Oppenheimer
10d ago
Incyte price target raised to $68 from $62 at Wells Fargo
Premium
The Fly
Incyte price target raised to $68 from $62 at Wells Fargo
10d ago
Incyte price target raised to $97 from $92 at Citi
Premium
The Fly
Incyte price target raised to $97 from $92 at Citi
10d ago
Incyte reports Q3 EPS $1.07, consensus $1.07
PremiumThe FlyIncyte reports Q3 EPS $1.07, consensus $1.07
11d ago
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
Innate Pharma appoints Jonathan Dickinson as CEO
Premium
The Fly
Innate Pharma appoints Jonathan Dickinson as CEO
26d ago
Incyte downgraded to Hold from Buy at Truist
PremiumThe FlyIncyte downgraded to Hold from Buy at Truist
2M ago
Incyte price target raised to $92 from $86 at Guggenheim
Premium
The Fly
Incyte price target raised to $92 from $86 at Guggenheim
2M ago
Incyte price target raised to $68 from $66 at BofA
Premium
The Fly
Incyte price target raised to $68 from $66 at BofA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100